May Hill Capital’s GSK GSK Stock Holding History

May Hill Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$524K	Buy	9,997 +53	+0.5%	+$2.8K	0.11%	124
2026 Q1	$549K	Buy	9,944 +1,764	+22%	+$95.6K	0.14%	101
2025 Q4	$401K	Buy	8,180 +256	+3%	+$11.9K	0.11%	124
2025 Q3	$342K	Sell	7,924 -1,999	-20%	-$78.1K	0.1%	132
2025 Q2	$381K	Buy	9,923 +514	+5%	+$19.6K	0.13%	115
2025 Q1	$365K	Buy	+9,409	New	+$344K	0.14%	109

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

May Hill Capital's GSK Position: Q2 2026 in Review

May Hill Capital increased its GSK (GSK) stake by 0.53% in Q2 2026, buying an estimated $2.8K and bringing the position to 9,997 shares worth $524K. The position accounts for 0.11% of the portfolio, ranked #124.

May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $549K in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

May Hill Capital held 9,997 shares of GSK worth $524K as of Q2 2026.
May Hill Capital bought 53 GSK shares in Q2 2026, an estimated $2.8K.
GSK made up 0.11% of May Hill Capital's portfolio in Q2 2026, its #124 holding.
May Hill Capital first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
May Hill Capital's GSK position peaked at $549K in Q1 2026.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.